Applicant, as named in the Orange Book
Emergent Biodefense
Next listed expiry: Tembexa on 30 Jul 2034. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Tembexa NDA 214460 brincidofovir | 30 Jul 2034 patent |
| Tembexa NDA 214461 brincidofovir | 10 Oct 2034 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.